« “Recreational” Drug Use: A New Discussion Category on the ASNet ForumWhy Distinguishing between Drug Dependence and Drug Addiction is Important »

Proposed Regulation of Salvia Divinorum

04/03/09 | by the professor [mail] | Categories: Drug-Regulation Policy

Salvia Divinorum and its concentrated extracts are enjoying unrestricted trade on the Internet and in most states throughout the United States. The Drug Enforcement Administration (DEA) is currently considering whether this substance (including its concentrated extracts and synthetic analogues) should be “scheduled” and placed on the controlled substance list. Because there are no medicinal uses of Salvia Divinorum recognized by the Food and Drug Administration (FDA), Salvia Divinorum and related compounds would most likely become Schedule I substances with access restricted to investigational use by DEA licensed researchers. (Click here for more information on the CSA/DEA Drug Classification System.)

The question open for comment is: Should Salvia Divinorum and its extracts become controlled substances? Secondary questions involve: How strong are the effects of this substance and its related analogues?

(Thanks to John Panos for suggesting a posting on this topic now open for commentary. Also thanks to my Advanced Topics in Addiction class for encouraging an interest in this substance.)

Related Topics on the ASNet
Distinguishing Drug Abuse from Drug Addiction
Drug Classification
Hard and Soft Drugs

May 2021
Sun Mon Tue Wed Thu Fri Sat
 << <   > >>
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31          

An open, unmoderated discussion forum for the Addiction Science Network, promoting free and open exchange of evidence-based information and promoting scientific analysis of drug addiction and related topics.


Addiction Science Network

blog software